Pharmaceuticals · Pharmaceuticals: Major · NSE: ACCENTMIC · data 2026-10-30

Accent Microcell Limited

₹639+0.79% on 30 OctHealth: Strong 9.1/10

Feb 2026Low ₹320.45 · High ₹725.75+91.7%

In plain words

Price: 12.7% below its 52-week high of ₹731.7.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹639

Market cap

₹1,521 cr

P/E

26.9

P/B

ROE

18.7%

ROCE

22.7%

Debt / equity

Dividend yield

0.16%

1-year return

140.2%

52-week high

₹731.7

52-week low

₹273

Operating margin

18.0%

Growth

Revenue (last 12 months)	₹385 cr
Net profit (last 12 months)	₹57 cr
Sales growth, 3 years (yearly)	20.9%
Profit growth, 3 years (yearly)	53.1%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Accent Microcell Limited debt-free?

Its latest reported debt-to-equity ratio is 0, so it carries little or no borrowing on the balance sheet.

What is Accent Microcell Limited's P/E ratio?

About 26.9, based on the last 12 months' earnings and a price of ₹639 (data 2026-10-30).

What is the 52-week high and low of Accent Microcell Limited?

The 52-week high is ₹731.7 and the 52-week low is ₹273.

Similar companies

Venus Remedies Limited (VENUSREM) · NGL Fine-Chem Ltd. (NGLFINE) · TTK Healthcare Limited (TTKHLTCARE) · Anlon Healthcare Limited (AHCL) · Bharat Parenterals Ltd. (BPLPHARMA)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ACCENTMIC in NSE Scanner →